Methods and systems for using rfid in biological field

ABSTRACT

Biological reagent carrier devices and methods are disclosed, which employ RFID techniques to associate information with biological reagents.

INTRODUCTION

The present teaching relates to methods and systems for associatinginformation with carriers for supporting biological reagents. During themanufacture and use of biological reagents, the reagents are typicallycoded and labeled in order to keep track of them. Conventional systemsuse bar codes to identify carriers containing reagents to be processedby analytical instrumentation. Bar codes, however, require printing andapplication of a bar code label to carriers for the biological reagents.At some later time the bar code is read by either a hand-held bar codescanner or by an automated bar-code scanner controlled by theinstrumentation to track the reagents as they are processed.

To read a label or a barcode, however, requires an optical path to thebarcode, which can be inconvenient and problematic, for example if theindicia to be read are located inside of an instrument. In the pastthese problems have been addressed by forming windows in the instrumentsor carriers to provide an optical path to the labels. Such windows cancomplicate the design of instruments and carriers and depending on theconfiguration and design of a particular window, the optical path can bedistorted, resulting in optical reading and scanning problems. Furtherreading problems can result from printing inconsistencies and anymaterial that covers the bar code, such as frost in a refrigerator.

Further, if information needs to be added to a label associated with aparticular sample, physical access is required to print the additionalinformation to the label. Moreover, only a limited amount ofinformation, can be printed on a label associated with a carrier due tolabel space limitations. When using bar codes, 1-D and 2-D bar codes arelimited as to how much information can be printed in a given amount ofspace by the visual resolution between marks. Therefore, typically aprinted carrier number or identifier is used as an index into a databaseof information regarding the carrier or the contents of the carrier. Thedatabase was typically provided on a separate CDROM or other removablemachine-readable medium. However, it can be inconvenient to associatethe information on particular CDROM with a particular carrier.

Vincogen Corporation of Trevose, Pa. purports to have filed U.S. patentapplication Ser. No. 10/396,269, on using RFID technology in connectionwith biochips to provide an identifier number for such biochips.However, the Vincogen product fails to address the above-identifieddeficiencies of existing methods and systems.

Accordingly, systems and methods are needed that provide for the readingfrom and writing to carriers for biological reagents without requiringan optical path or direct physical access to the carriers. Moreover,there is need for storing greater amounts of information than can bewritten on a conventional label. SUMMARY

According to various embodiments, apparatus is provided for associatinginformation with a biological reagent according to the presentteachings. The apparatus can include a carrier for supporting thebiological reagent and at least one RFID tag including a carrier RFIDantenna coupled to the carrier, wherein the RFID tag is operable to beread by an RFID reader, and the RFID tag can include identification,supplemental, and/or rights information for the biological reagent.

According to various embodiments, apparatus is provided for associatinginformation with a microarray according to the present teachings. Theapparatus can include a substrate; at least one chamber coupled to themicroarray; and an RFID tag having an RFID antenna coupled to thesubstrate.

According to various embodiments, apparatus is provided for associatinginformation with a biological reagent according to the presentteachings. The apparatus can include a carrier for the biologicalreagent. The carrier is coupled to an RFID tag, and the RFID tag isoperable to be read by an RFID reader. The RFID tag containsidentification information. Further, an instrument is provided forreading the identification information, and performing operations on thebiological reagent, the instrument including an output for providing anidentity indication of the biological reagent based on theidentification information. The instrument is generally opaque andblocks optical paths to contents of the instrument.

According to various embodiments, the present teachings involve methodsfor associating information regarding biological reagents with carriersfor supporting the biological reagents. A carrier for the biologicalreagents is provided, and the carrier is coupled to an RFID tag so thatthe RFID tag can be read by an RFID reader. Identification,supplemental, and/or, rights information associated with the biologicalreagent is received from the RFID tag.

According to various embodiments, apparatus for associating informationwith a biological reagent is provided. The apparatus includes a carrierfor supporting the biological reagent and an RFID tag including acarrier RFID antenna coupled to the carrier. The RFID tag can be read byan RFID reader, and the RFID tag includes instrument operationinformation for the biological reagent.

According to various embodiments, a method for associating informationregarding operations for biological reagents with carriers forsupporting the biological reagents is provided. The method includesproviding a carrier for at least one biological reagent, the carriercoupled to an RFID tag, which can be read by an RFID reader. The methodalso includes receiving, from the RFID tag, instrument operationinformation associated with the biological reagent.

It is understood that both the foregoing general description and thefollowing description of various embodiments are exemplary andexplanatory only and are not meant to be restrictive or to be read intothe claims. The accompanying drawings, which are incorporated in andconstitute a part of this specification, illustrate some embodiments,and together with the description serve to explain the principles of theembodiments described herein.

BRIEF DESCRIPTION OF THE DRAWINGS

The skilled artisan will understand that the drawings, described below,are only intended for the illustration of various embodiments. Thedrawings are not intended to limit the scope of the present teachings inany way.

FIG. 1 illustrates a perspective view from above a reaction plate havinga plurality of reaction wells and various exemplary locations for RFIDtags according to various embodiments;

FIG. 2 illustrates a perspective view from beneath a reaction platehaving a plurality of reaction wells and various exemplary locations forRFID tags according to various embodiments;

FIG. 3 illustrates a tube in connection with various exemplary locationsfor RFID tags according to various embodiments;

FIG. 4 illustrates an embodiment of an empty tube carrier in connectionwith various exemplary locations for RFID tags according to variousembodiments;

FIG. 5 illustrates a tube carrier containing a plurality of tubes inconnection with various exemplary locations for RFID tags according tovarious embodiments;

FIG. 6 illustrates an exemplary embodiment of a surface plasmonresonance (SPR) array in connection with various exemplary locations forRFID tags according to various embodiments;

FIG. 7 illustrates another exemplary embodiment of a reaction plate inconnection with various exemplary locations for RFID tags according tovarious embodiments;

FIG. 8 illustrates an exemplary embodiment of a microfluidic card inconnection with various exemplary locations for RFID tags according tovarious embodiments;

FIG. 9 illustrates an exemplary embodiment of a microarray cartridge inconnection with various exemplary locations for RFID tags according tovarious embodiments;

FIG. 10 illustrates an exemplary embodiment of a microarray inconnection with various exemplary locations for RFID tags according tovarious embodiments;

FIG. 11 illustrates an exemplary embodiment of an on-line biologicalinstrument system according to various embodiments;

FIG. 12 illustrates an exemplary embodiment of an RFID writing apparatusaccording to various embodiments; and

FIG. 13 illustrates an exemplary embodiment of RFID tag tracking systemsaccording to various embodiments.

DESCRIPTION OF VARIOUS EMBODIMENTS

Reference will now be made in detail to some embodiments, examples ofwhich are illustrated in the accompanying drawings. Wherever possible,the same reference numbers are used throughout the drawings to refer tothe same or like parts.

Radio Frequency Identification (“RFID”) provides a convenient mechanismfor identifying and detecting objects using wireless electro-magneticsignals. A basic RFID system has at least one RFID reader and at leastone RFID tag. Typically, RFID readers can include a coil or antenna andcircuitry to transmit and receive signals with the coil or antenna. AnRFID tag also includes a coil or antenna and some information that canbe read by an RFID reader.

The RFID reader antenna generates an electromagnetic field, therebytransferring energy to the tag. Depending on the design of the tag, aportion of the energy transferred to the tag will be reflected to thereader so as to provide information about the tag back to the reader.Some RFID systems can be used to read and optionally write data to andfrom the RFID tag. RFID readers can generate signals spanning distancesfrom less than one inch to more than 100 feet depending on frequency andpower of the signals generated at the RFID reader antenna.

Typically, RFID tags are categorized as either active or passive. ActiveRFID tags are powered by an internal battery and are typicallyread/write, i.e., tag data can be rewritten and/or modified. An activetag's memory size varies according to application requirements; somesystems operate with up to 1 MB of memory.

Passive RFID tags operate without a separate external power source andobtain operating power generated from the reader. Passive tags areconsequently typically lighter than active tags, less expensive, andoffer a long operational lifetime. Passive tags typically have shorterread ranges than active tags and require a higher-powered reader.Read-only tags are typically passive and are can be programmed with aunique set of data (usually 32 to 128 bits) that is typicallypredetermined at the time of manufacture of the tag. It is understoodthat passive read/write tags can also be employed consistent with thepresent teachings.

The term “RFID tag” as used herein refers to either an active or passiveRFID tag that contains information. The RFID tag can be read only orread/write, and the information associated with the RFID tag can behard-coded into the RFID tag at the time of manufacture or at some latertime, or the RFID tag can contain information that is written to theRFID tag throughout its lifetime.

The term “RFID reader” as used herein includes RFID devices that canread information from and/or write information into an RFID tag.

The term “carrier” as used herein refers to a structure for directly orindirectly supporting a biological reagent. Examples of carriers includereaction plates, tubes, tube carriers, surface plasmon resonance arrays,slides, conical low-volume tubes, microfluidic cards, microarraycartridges, microarrays, and other types of containers for supportingbiological reagents.

The term “biological reagent” as used herein refers to a biologicalmaterial used for various biological analyses such as detecting,examining, and/or measuring information from biological samples.Biological analyses can include reactions such as polymerase chainreaction (PCR), ligase chain reaction, antibody binding reaction,oligonucleotide ligation assays, and hybridization assays. Examples ofbiological reagents include nucleic acids, primers, probes, and otherbiological reagents, which can be used in performing various biologicalassays. “Nucleic acid” as used herein refers to nucleotides,oligonucleotides, DNA, RNA, PNA, etc. as these terms are understood bythose skilled in the art of genomics.

The term “information” as used herein refers to data that can be storedelectronically in the RFID tag and can be retrieved to be used asmachine readable or human readable data for processing the biologicalreagent and/or carrier.

The term “identification information” as used herein refers toinformation on an RFID tag that can be used to uniquely identify aparticular carrier or biological reagent or to distinguish the carrieror biological reagent from other carriers or biological reagents. Forexample, identification can relate a particular assay prepared for aparticular customer.

The term “supplemental information” as used herein refers to descriptiveinformation about a carrier or its contents, including certainbiological reagents. Examples of supplemental information includenucleic acid sequence information and annotated information regardingexperiments performed with various biological reagents.

The term “rights information” as used herein refers to authorizationinformation for carriers or biological reagents, such as informationregarding whether a particular licensee has a valid license to use aparticular carrier or biological reagent, including a number of timesthe licensee is permitted to use the particular carrier or biologicalreagent in a particular assay. Rights information can also includevalidation information regarding whether a particular carrier orbiological reagent has been subject to a recall or has otherwise becomeunsuitable or unauthorized for use.

The term “genealogy information” as used herein refers to informationregarding the derivation of a biological reagent, including for examplean identification of an original sample from which it was derived or thenumber of generations removed it is from an original sample.

The term “traveler information” as used herein refers to informationregarding a carrier or a biological reagent contained as operations areperformed on that carrier or biological reagent for example duringmanufacture of the biological reagent or while an assay is beingperformed on the biological reagent.

FIG. 1 illustrates a perspective view from above of a reaction plate 100having a plurality of reaction wells 102 and exemplary locations 110,112, 114, and 120 for RFID tags. It is understood that exemplarylocation 110 for the RFID tag, for example, can be positioned on theexterior of the reaction plate 100 in any convenient location that willpermit appropriate antenna geometry and accommodate the necessarypassive or active RFID circuitry necessary for proper operation of theRFID tag. For example, RFID tags 110 and 112 are shown as boxes placedin the margins of the reaction plate 110 on an upper surface 116 of thereaction plate 100. Adhesive application of an RFID tag to the surface116 of the reaction plate 100 can advantageously permit standardconsumables, such as reaction plate 100 to be manufactured and/oracquired independently from the RFID tags. Alternatively, RFID tag 120,illustrated in broken lines, can be embedded in the reaction plate 100,for example during a plastic injection molding or a blow moldingmanufacturing process. Trays and microcards are typically constructed ofpolypropylene so as to be compatible with PCR thermal cycling. Othercarriers that provide transport containers as opposed to reactioncontainers can be made of harder plastics e.g. Lexan® (GeneralElectric). FIG. 1 illustrates a 96-well reaction plate. As illustratedin FIG. 7, other reaction plates such as 386-well reaction plates arecontemplated by the present teachings.

FIG. 2 illustrates an underside perspective view of the reaction plate100 showing the undersides 204 of a plurality of reaction wells and atleast one RFID tag 202 affixed to an underside portion of the reactionplate. As shown in FIG. 2, the RFID tags can be placed on the undersideof the carrier as shown in connection with RFID tags 202 and 206, whichare shown to be applied to the surface 216 of the reaction plate 100.Alternatively, an RFID tag 208 can be applied to a side surface of thereaction plate 100. As set forth in connection with FIG. 1, in variousembodiments, the RFID tags can, for example, be adhesively applied toconsumables, such as on the reaction plate 100. However, the RFID tagscan also be embedded in the body of the consumables, for example duringa plastic injection molding or a blow molding manufacturing process. Tofacilitate a transition from barcodes to RFID, both barcodes (not shown)and RFID tags can be present on consumables consistent with the presentteachings, such as the reaction plate 100.

According to various embodiments, the reaction plates contain biologicalreagents such as nucleic acid materials, primers, and probes, which areused in connection with various biological assays to determine, forexample a genetic sequence of a particular sample. In variousembodiments, separate RFID tags on the plate are associated with groupsof wells within the reaction plate. In other embodiments, an RFID tag isassociated with a single well in the reaction plate 100. In otherembodiments, a single RFID tag is associated with the entire reactionplate, with the RFID tag containing information regarding each of thewells and the contents and history of the contents of each of the well.In such embodiments, a read/write RFID tag containing a substantialamount of memory can include, for example, identification, supplemental,and/or rights information about the contents of the wells 102 (of FIG.1).

FIG. 3 illustrates a tube 300 having RFID tags positioned in alternativeconfigurations on the tube 300. The tubes can have a conical internalvolume to provide pipette access to small volumes. In variousembodiments, the tubes bear both human-readable and/or machine-readableindicia regarding the contents of the tube and/or barcodes in additionto an RFID tag. In various embodiments, the RFID tag is adhesivelyapplied to outer surface 306 of the tube 300 in connection with a labelfor providing optically-accessible indicia. In various embodiments, RFIDtags are provided in the form of printable labels containing an RFID tagintegral with the label. The RFID tags can also be affixed to orembedded in a bottom portion of the tube, as shown by RFID tag 304 inFIG. 3. Tubes can store nucleic acids for assays designed for aparticular customer or for a particular assay.

FIG. 4 illustrates an embodiment of an empty tube carrier having an RFIDpositioned at various locations. Tube carriers such as tube carrier 400are advantageously used to organize and transport a plurality of thetubes 300 containing biological materials. Lid 402 and tube carrier base404 are used to protect and/or to store the tubes 300 duringmanufacturing, storage, transportation, and usage phases of thelifecycle of the biological materials supported by the tubes 300. Invarious embodiments, RFID tags in or on the tubes contain informationregarding nucleic acid samples, primers, or probes contained in each ofthe tubes. In such embodiments information regarding the geneticsequences of the nucleic acids, for example, are stored in the RFIDtags. Further, annotated information regarding the biological reagentscan be stored in the RFID tags, for example, information regardingresults of experiments already performed with the biological reagents.

According to various embodiments, no read/write RFID tag is directlycoupled to a particular tube. Rather, the tube bears a simplified RFIDtag or optical indicia that provides, for example, row and columninformation for the tube's position in the tube carrier 400. Then, forexample, information regarding the contents of tubes can be stored in amore complex RFID tag that is affixed to or embedded into the tubecarrier 400, either at the lid 402 or at the carrier base 404.Alternatively, additional information can be stored on a CDROM or otherremovable medium and associated with each tube, for example, based on aunique identifier on the RFID tag associated with the tube or tubecarrier. The additional information can also be provided in an encryptedon-line database, as further set forth in connection with FIG. 11.

Exemplary RFID tag positions are illustrated in connection with FIG. 4.An RFID tag 408 can be applied to a surface of the lid 402.Alternatively, an RFID tag 406 can be applied to a surface of the tubecarrier base 404. Still alternatively, the RFID tag 410 can be embeddedinto a portion of the tube carrier 400 during a manufacturing process ofthe tube carrier 400. It is understood that the positions of the RFIDtags 406, 408, and 410 are exemplary any not inclusive and that a singleor multiple RFID tags can be affixed to or embedded into variousportions of the tube carrier 400 without departing from the presentteachings.

FIG. 5 illustrates a tube carrier containing a plurality of tubes havingassociated individual RFID tags and at least one RFID tag on the tubecarrier; In various embodiments, as shown in FIG. 5, tube carriers, suchas the tube carrier 400 can contain a plurality of the tubes 300. Inthese various embodiments, information regarding the contents of thetubes, including, for example nucleic acid sequence information, andother annotated information is stored in an RFID tag either affixed toor embedded into each of the tubes 300 or in an RFID tag that is affixedto or embedded into the tube carrier 400.

According to various embodiments, the tube carrier 400 can contain asimplified RFID tag containing only an identifier number, which iscross-referenced to a table that contains information on the contents ofparticular the tubes 300 in the particular tube carrier 400. In variousembodiments, the lookup table information is provided on removable,machine-readable media, such as CDROM. In various other embodiments, thelookup table information is provided in the form of anetwork-accessible, on-line database. In various ones of theseembodiments, the lookup table information is encrypted either in anoff-line CDROM-type form or in an on-line form.

According to various embodiments, authentication and/or decryptioninformation can be stored in the RFID tag or tags on or in the tubes 300and/or the tube carrier 400. It is understood that any type of digitalauthentication and/or cryptography system can be employed to provideaccess to and decryption for the on-line or off-line data associatedwith the biological contents of the carriers without departing from thescope of the present teachings.

FIG. 6 illustrates an exemplary embodiment of an SPR array 600 withexemplary RFID tags 604 and 602. The SPR array 600 contains ports 606that are used to inject a biological reagent into the SPR array. Invarious embodiments, RFID tags 602 and 604 facilitate the association ofinformation with biological reagents used in connection with the SPRarray 600. For example, read/write RFID tag 602 can contain informationregarding the biological sample injected into the SPR array. The RFIDtag 602 can also be written to by an instrument that is used to detectthe results of an assay conducted on the biological reagent that isinjected into the SPR array. The RFID tag can further store informationregarding locations and patterns of particular nucleic acid spots in theSPR array.

As described above in connection with other consumables, the RFID tags602 and 604 can be affixed to an outer surface of the SPR array 600 (asshown with RFID tag 602) or embedded in the SPR array during manufacture(as shown with RFID 604). In various embodiments the SPR array isconstructed from a standard glass slide which has a layer of golddeposited to an underside surface of the slide, and the RFID tag isadhesively applied to an upper surface 610 of the glass slide.

FIG. 7 illustrates another exemplary embodiment of a reaction plate 700with at least one associated RFID tag. As described in connection withFIGS. 1 and 2, reaction plates such as the reaction plate 700 can becoupled to an RFID tag to facilitate the association of information withthe biological contents of the reaction plate. For example, an RFID tag702 can be applied to an exterior surface of the reaction plate 700, oran RFID tag 704 can be embedded within a portion of the reaction plate.Any reaction plate with 8, 16, 24, 48, 96 (FIG. 1), 386 (FIG. 7), etc.is contemplated by the present teachings.

FIG. 8 illustrates an exemplary embodiment of a microfluidic card 800having at least one associated RFID tag. The microfluidic card 800provides an array containing multiple chambers 814 for testing variousbiological reagents on many different primer and probe sets thereby, forexample, eliminating labor-intensive pipetting steps. In connection withthe microfluidic card 800, biological reagents can be injected into thecard via inlet ports 810 through channels 812 into the clambers 814.

According to various embodiments, information regarding the contents ofthe chambers and/or the contents loaded into the card can be provided.Accordingly, RFID tags consistent with the present teachings are affixedto a surface of a portion of the microfluidic card 800 for example onsurface 804 as shown in connection with RFID tag 806. The RFID tag 808is shown as being embedded into a portion of the microfluidic card 800.It is understood that the RFID tag can be affixed to or embedded inother portions of the card, such as the supporting lid portion 802,which has a plurality of apertures, through which the chambers 814 canbe observed by an instrument to determine the results of an assayperformed in connection with the microfluidic card 800. The RFID tag 806can include information regarding specific assays preloaded into themicrofluidic card. Further, the RFID tag 806 can include informationregarding samples injected into the card, which is written to the RFIDtag as the samples are being injected into the card.

FIG. 9 illustrates an exemplary embodiment of a microarray cartridge 900with at least one associated RFID tag. The microarray cartridge 902 isprovided to facilitate the protection and loading of a microarray onmicroarray slide 1000 as illustrated in FIG. 10. In various embodiments,the microarray cartridge 900 is substantially opaque which does notallow for the optical reading of information from the microarray slide1000. However, consistent with the present teachings, RFID taginformation can be read regarding the contents of the microarray slide1000 even absent an optical path in the microarray cartridge 900.Additionally, information regarding the microarray contained within themicroarray cartridge 900 can be stored in RFID tag 904, which can beaffixed to an outer surface 902 of the microarray cartridge 900. Invarious embodiments, the RFID tag 906 can be embedded in a wall portionof the microarray cartridge 900.

FIG. 10 illustrates an exemplary embodiment of the microarray slide 1000having at least one RFID tag associated with the microarray 1010. RFIDtags 1006 and 1008 are shown as alternatively being embedded insubstrate 1004 or as being affixed to an outer surface portion of thesubstrate 1004. It is understood that RFID tags can be positioned in anyconvenient configuration on the microarray slide 1000, including, forexample along an outer periphery of the microarray slide 1000, along anouter periphery of the gasket 1002 positioned around microarray 1010 oron an underside surface of the substrate 1004 without departing from thescope of the present teachings.

According to various embodiments, information can be stored in RFID tagsassociated with any of the above-described consumables that can beuseful, for example, in the transportation of the biological reagents.For example, in connection with the importation and/or exportation ofbiological reagents, biological reagent content information and countryof origin information can be provided consistent with the presentteachings. National customs agencies typically require the provision ofsuch country of origin information during import and/or export ofvarious biological reagents. It is understood that the provision of suchinformation by way of an RFID reader interface would drasticallyexpedite the provision to customs authorities of, for example, countryof origin information for various biological reagents.

According to various embodiments, Material Safety Data Sheet (MSDS)information can be stored in the RFID tags and read at any time duringthe lifecycle of the biological reagent while it is contained in orsupported by a carrier consistent with the present teachings.

According to various embodiments, the information stored in the RFIDtags associated with the biological reagents can include travelerinformation that is written to the RFID tag at various stages or stepsalong the course of a biological assay. In various embodiments,genealogy data is read and used during the course of an assay.

According to various embodiments, biological samples or reagents thatare provided in the carriers described above are licensed separatelyfrom instruments designed to operate on the biological reagents. Invarious embodiments the instruments are coupled to a network (see e.g.FIG. 11) that allows the instruments to communicate over public andprivate networks with computer systems that are operated by or on behalfof the producers and/or licensors of the biological reagents. In variousembodiments, reagent licenses can provide for the use of licensedbiological reagents for a particular biological analysis on onlylicensed instruments. In various embodiments, instrument licenses canprovide for the use of licensed instruments to carry out a particularbiological analysis with only licensed reagents. Accordingly, aninstrument can authenticate a biological reagents based on, for example,a digital signature contained in the RFID tag associated with aparticular consumable, if a particular user has a valid license. INvarious embodiments, the RFID tags can also be programmed to provide aone time use such that biological reagents cannot be refilled with foruse with the same authentication.

According to various embodiments, when an RFID tag is read by aninstrument that has access to a data network that includes a connectionto information regarding biological reagent recall information, theinstrument can perform a database lookup to determine whether thebiological reagent has been subject to a recall. The recall informationand an optional last recall check date and/or timestamp can be writtento the RFID tag. In various embodiments, a recall database lookup isperformed each time before a biological reagent is utilized in an assayor other test such as, for example a clinical diagnostic procedure.

According to various embodiments, external displays are provided todisplay information regarding the biological reagent contents of aconsumable when the biological reagent is inside of an instrument orother container, such as a refrigerator. For example when a microarrayis contained within its microarray cartridge, an RFID reader can readthe identification information from the microarray and display it on ahuman readable interface, such as a computer terminal, LCD, or othertype of display.

FIG. 11 illustrates an exemplary embodiment of an on-line biologicalinstrument system 1100 consistent with the present teachings. In variousembodiments, a general purpose computer 1110 serves a function ofcontrolling an instrument 1106 as it performs operations on biologicalreagents supported by carriers 1108. RFID tags 1109 that are affixed onor embedded into the carriers 1108 can be read by and/or written to bythe RFID reader 1107. In various embodiments, the RFID reader 1107 canread identification information from the RFID tag 1109 to identify thebiological reagent being supported by the carrier 1108 at particularpoints in time. In various embodiments, identifying descriptions, suchas the name or work number associated with the biological reagent can bedisplayed on the monitor of the general purpose computer 1110. Invarious other embodiments, the identifying descriptions can be providedon a display (not shown) that is externally connected to the instrument1106.

Via a network connection 1105, the instrument 1106, and/or the generalpurpose computer 1110 can be connected to a public or private network,such as internet 1104. It is understood that any networking technologycan be employed without departing from the present teachings, includingwired and wireless networking technologies. It is also understood that,in various embodiments, the network connection associated with theinstrument 1106 can emanate from the instrument 1106 as shown or fromthe general purpose computer 1110.

By employing a network connection, the instrument 1106 and/or itsassociated general purpose computer 1110 can remotely access databases1120, 1130, 1140, and 1150 via remote network connections 1103. Invarious embodiments, information contained in the databases 1120, 1130,1140, and 1150 can be written to the RFID tag 1209 as set forth below inconnection with FIG. 12. In various embodiments, the database 1120 caninclude identification information. In various embodiments, the database1130 can include supplemental information, such as annotated informationregarding a biological reagent. In various embodiments, the database1140, can include rights information, which as set forth above can beused to authenticate or validate the biological reagent and/or determinethe validity of licenses associated with the biological reagent. Invarious embodiments, databases 1140 can include information used tocheck for any product recalls associated with the biological reagent. Invarious embodiments, the database 1150 can contain information regardinginstrument operations. In various embodiments, connections to thedatabases are encrypted for privacy. In various embodiments, thecontents of the databases 1120, 1130, 1140, and 1150 are encrypted forconfidentiality and to facilitate access control to the informationcontained in the databases 1120, 1130, 1140, and 1150.

According to various embodiments, the instrument 1106 includesinstrument hardware, instrument firmware, instrument data acquisitionand control software, and method or module data. In various embodiments,the instrument hardware includes electronic control and data processingcircuitry, such as a microprocessor or microcontroller, memory, andnon-volatile storage. In various embodiments, the instrument hardwarealso includes physical devices to manipulate biological reagents such asrobotics and sample pumps. In various embodiments, the instrumentfirmware includes low-level, computer-readable instructions for carryingout basic operations in connection with the instrument hardware. Invarious embodiments, the instrument firmware includes microprocessorinstructions for initializing operations on a microprocessor in theinstrument hardware.

According to various embodiments, the instrument data acquisition andcontrol software is higher-level software that interfaces with theinstrument firmware to control the instrument hardware for more specificoperations such as operating a charge coupled device (CCD) to acquirevisual luminescence information regarding a particular biologicalanalysis. In various embodiments the data acquisition and controlsoftware includes a software-implemented state machine providing, forexample, the following states: (i) idle; (ii) running; (iii) paused; and(iv) error. In various embodiments, when the state machine is in theidle state, it can receive an instruction from the general purposemachine 1110 to perform a particular data acquisition or instrumentcontrol operation. In various embodiments, the general purpose computer1110 opens a TCP/IP socket connection to the instrument 1106, determineswhether the instrument 1106 is in the idle state and then beginstransmitting instructions and/or parameters. In various embodiments, anencrypted TCP/IP connection is established, using, for example, the SSHprotocol. The instructions and/or parameters can be in the form of ASCIIencoded, human readable module and/or method information that definesthe behavior of the biological instrument. In various embodiments, themodules and/or methods are stored in the form of ASCII text files. Invarious embodiments, the general purpose computer 1110 uses the FTPprotocol to transfer the ASCII text files to the instrument 1106. Invarious other embodiments the method and/or module information is storedin and read from the RFID tag 1109. The method and/or module informationcan be stored in the form of an ASCII text file in the RFID tag 1109,but it is understood that the information can be represented in otherdata formats without departing from the present teachings. In variousembodiments, methods and module information is stored in a relationaldatabase, such as those available from the Oracle Corporation of RedwoodShores, Calif.

According to various embodiments, the module, macro, and/or methodinformation includes parameters that can be used by the instrument dataacquisition and control software to perform specific data acquisitionand instrument control operations. In various embodiments, the methodand/or module information contains sequences of operations to beperformed by the instrument or control parameters for use in connectionwith the data acquisition or control software.

FIG. 12 illustrates an exemplary embodiment of an RFID writing apparatus1200 consistent with the present teachings. RFID carrier 1108 is shownwith an associated read/write capable RFID tag 1209. In variousembodiments, an RFID reader 1202, having RFID read and writecapabilities and antenna 1204, is coupled to the databases 1120, 1130,1140, and 1150 including identification, supplemental, rights, andinstrument operation information respectively. In this configuration anycombination of identification, supplemental, rights, and/or instrumentoperation information can be written to the RFID tag 1209 consistentwith the present teachings.

FIG. 13 illustrates an exemplary embodiment of RFID tag tracking systems1300 consistent with the present teachings. A warehouse 1306 ormanufacturing facility includes one or more RFID readers 1308, which canbe used to read RFID tags on carriers such as carrier 1108 as thecarriers move throughout the warehouse 1306 or manufacturing facility.The RFID readers 1308 can be used for inventory control and to providereal-time product location information. In various embodiments aninstrument 1106 can perform operations on a biological reagent beingsupported by the carrier 1108, while the RFID reader 1308 providesgeneral location information regarding a location of the carrier 1108.Moreover, the external RFID reader 1304 can read from and/or writeinformation into the RFID tag 1109. In various embodiments, external,hand-held RFID readers such as the RFID reader 1304 can be used to writeto or read information from the RFID tags 1109. According to variousembodiments, obtaining the real-time physical location coordinates of acarrier can be achieved by receiving GPS coordinates from a GPS receiverphysically coupled to the carrier.

The section headings used herein are for organizational purposes onlyand are not to be construed as limiting the subject matter described inany way.

All literature and similar materials cited in this application,including but not limited to, patents, patent applications, articles,books, treatises, and internet web pages, regardless of the format ofsuch literature and similar materials, are expressly incorporated byreference in their entirety for any purpose.

While the present teachings are described in conjunction with variousembodiments, it is not intended that the present teachings be limited tosuch embodiments. On the contrary, the present teachings encompassvarious alternatives, modifications, and equivalents, as will beappreciated by those of skill in the art.

What is claimed: 1-69. (canceled)
 70. A biological device comprising: ahousing; at least one opening in the housing, wherein the at least oneopening is configured to receive at least one carrier containing abiological reagent and having an RFID tag affixed thereto or embeddedtherein; a processor; and a memory encoded with instructions executableby the processor, wherein the instructions include instructions for:interrogating the RFID tag for identification information, andcontrolling the biological device based on the identificationinformation, wherein controlling the biological device includes usingthe identification information to restrict use of the biological device.71. The device of claim 70, wherein the identification informationincludes authentication information.
 72. The device of claim 70,comprising an RFID reader coupled to the housing and configured tointerrogate the RFID tag.
 73. The device of claim 70, whereinrestricting the use of the biological device is restricting the numberof times the biological reagent is used.
 74. The device of claim 73,wherein restricting the use of the biological device is restrictingconsumable use to a one time use.
 75. The device of claim 70, whereinthe processor is configured to communicate over a network with adatabase.
 76. The device of claim 75, wherein the database includesinformation to validate the identification information.
 77. The deviceof claim 75, wherein the database includes information regardinginstrument operation.
 78. The device of claim 70, wherein thecontrolling comprises comparing the identification information to alook-up table.
 79. The device of claim 70, wherein the device comprisesa display.
 80. The device of claim 79, wherein the display is configuredto display a message to a user based on the identification information.81. The device of claim 70, wherein the device is a sequencer.
 82. Abiological device comprising: a housing; an RFID reader, wherein theRFID reader is capable of interrogating an RFID tag associated with areagent carrier; and a processor capable of processing information fromthe RFID reader, wherein the processor is capable of determining fromthe processed information whether the reagent carrier is authorized foruse.
 83. The device of claim 83, wherein the information is an uniqueidentifier associated with the RFID tag.
 84. The device of claim 83,wherein the device includes a network connection configured to connectto a remote database.
 85. The device of claim 84, wherein the remotedatabase is a database of unique identifiers associated with RFID tags.86. The device of claim 84, wherein the device includes a barcodereader.
 87. The device of claim 82, wherein the device includes adetector configured to monitor a biological analysis.
 88. The device ofclaim 87, wherein the biological analysis is sequencing.
 89. The deviceof claim 87, wherein the biological analysis is amplification a nucleicacid sequence.